Task-shifting strategy for HTN control (TASSH) protocol for High Blood Pressure

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
High Blood Pressure+1 MoreTask-shifting strategy for HTN control (TASSH) protocol - Behavioral
Eligibility
18 - 85
All Sexes
What conditions do you have?
Select

Study Summary

This trial looks at how well a task-strengthening strategy for hypertension control works when integrated into primary health care for people living with HIV in Lagos, Nigeria.

Eligible Conditions
  • High Blood Pressure
  • HIV/AIDS

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

1 Primary · 8 Secondary · Reporting Duration: baseline, 6 months, 12 months, 18 months and 24 months

12 months
The rate of adoption of TASSH across participating primary health centers (PHCs) at 12- and 24 months respectively.
Month 24
Change in Implementation Climate of Mediators of TASSH across the primary health centers (PHCs) at 12 and 24 months.
Change in Implementation Leadership of Mediators of TASSH across the primary health centers (PHCs) at 12 and 24 months.
Change in Organizational Readiness of Mediators of TASSH across the primary health centers (PHCs) at 12 and 24 months.
Change in Organizational capacity to change across the primary health centers (PHCs) at 12 and 24 months.
Change in Proficiency of Mediators of TASSH across the primary health centers (PHCs) at 12 and 24 months.
Change in implementation process across the primary health centers (PHCs) at 12 and 24 months.
24 months
The rate of sustainability of TASSH across participating primary health centers (PHCs) at 12- and 24 months respectively.
Month 24
Change in systolic Blood Pressure

Trial Safety

Trial Design

2 Treatment Groups

Self-directed without Practice Facilitation (PF)
1 of 2
With Practice Facilitation (PF)
1 of 2

Active Control

Experimental Treatment

960 Total Participants · 2 Treatment Groups

Primary Treatment: Task-shifting strategy for HTN control (TASSH) protocol · No Placebo Group · N/A

With Practice Facilitation (PF)
Behavioral
Experimental Group · 1 Intervention: Task-shifting strategy for HTN control (TASSH) protocol · Intervention Types: Behavioral
Self-directed without Practice Facilitation (PF)NoIntervention Group · 1 Intervention: Self-directed without Practice Facilitation (PF) · Intervention Types:

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: baseline, 6 months, 12 months, 18 months and 24 months

Who is running the clinical trial?

NYU Langone HealthLead Sponsor
1,263 Previous Clinical Trials
752,637 Total Patients Enrolled
National Heart, Lung, and Blood Institute (NHLBI)NIH
3,589 Previous Clinical Trials
46,944,847 Total Patients Enrolled
Olugbenga Ogedegbe, MDPrincipal InvestigatorNYU Langone Health
1 Previous Clinical Trials
640 Total Patients Enrolled

Eligibility Criteria

Age 18 - 85 · All Participants · 4 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You have a diagnosis of HTN with uncontrolled blood pressure, i.e.
You have a minimum age of 18 years.\n
You have the ability to give informed consent.\n

Who else is applying?

What state do they live in?
Missouri100.0%
What portion of applicants met pre-screening criteria?
Met criteria100.0%